3.12 Flashcards

1
Q

Streptococcus
pyogenes

”—“-forming

A

pus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Some streptococci are typically seen

as

A

diplo-cocci:

Streptococcus pneumoniae

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

b-hemolysis (top) on blood-agar plates causes

A

clearing at and around colonies in

Streptococcus pyogenes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

a-hemolysis (bottom) shows greening due to partial lysis of erythrocytes in (2)

A

S.mitis and

S.pneumoniae.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q
pneumolysin degrades
hemoglobin  green
Green color sheen has
given the name
--- to many αhemolytic Streptococci
like the caries-causing:
S.mutans, S.mitis,
S.salivarius, S.sanguis
A

viridens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Rapid strep throat test (2)

A

is based on Group A
serological response.
Useful for rapid distinction from viral strep throat
in school children (but culture must be done)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Sequencing of the emm gene for the required virulence factor protein —has
become more important than Lancefield antigens to identify strains.

A

M

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

M protein - (3)

A

cell wall component, >100 serotypes, membraneanchored: is an important virulence factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

anti-M antibodies prevent infection of S.pyogenes but many serotypes.
So protective immunity is

A

type-specific

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

• M protein binds —, the main cell type in outer skin layer

A

keratinocytes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

M protein binds —, blocking surface from complement system

components

A

fibrinogen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

M protein binds complement control proteins

• Inhibits formation of —by complement cascade

A

opsonins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ø capsule:

A

antibodies are ineffective against glycocalyx-covered surface antigens

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Group A strains have capsules of (1), mimicking

mammalian connective tissues, preventing phagocy

A

hyaluronic acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ø F protein

A

(cell wall adhesin) provides adherence to the fibronectin of throat epithelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Ø lipoteichoic acid

A

(species-specific form) also adheres to the fibronectin epithelial cell coat

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Ø M protein also shows adhesion for — and strong adhesion to —

A

fibronectin

keratinocytes (skin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Adhesion-based uptake of cocci into epithelial cells is likely a basis for the repeated
nature of

A

strep throat and deep tissue infections.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q
  1. M protein anti-complement action through
A

Factor H

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q
  1. Capsular C3 peptidase destroys opsonizing — complement opsonization
A

C3b

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Thus: CR1 does not work! Phagocytosis only by

A

IgG opsonization (FcR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Ø G protein (cell surface) binds Fc of IgG, preventing

A

phagocytosis based on FcReceptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Ø — peptidase in Group A Streptococci

A

C5a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

c3b peptidase cleaves the complement component into — fragments

A

inactive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
inactivate complement chemotaxin c5a; activate surface of --- to --- and cleave of c3b
plasminogen | plasmin
26
``` membrane damagin toxins (cytotoxins) fxn toxin: streptococcus pyrogenes name of disease; name of toxin characteristic of the disease mechanism ```
disrupts the plasma membrane pharyngitis and other infections; streptolysin O accumulation of pus inserts into membranes, forming pores that allow fluids to enter
27
streptolysins S, O:
lysis of erythrocytes (direct lysis; basis of β-hemolysis) and of phagocyte lysosomal membranes (indirect lysis of leukocytes)
28
secretion of tissue degrading enzymes (4)
DNase, protease, hyaluronidase (spreading factor), streptokinase (degrades blood clots)
29
streptokinase is clinically useful in early vascular attack treatment because it
activates plasminogen | and the resulting plasmin will degrade fibrin clots formed in stroke and heart infarct.
30
``` superantigens: fxn toxin: streptococcus pyogenes (certain strains) name of disease; name of toxin characteristic of the disease mechanism ```
overrides the specificity of the t cell response streptococcal toxic shock; streptococcal pyrogenic exotoxins (SPE) fever, vomitting, diarrhea, muscle aches, rash, low bp systemic toxic effects due to the resulting massive release of cytokines
31
Cytokines:
IL2, TNF-β, IFN-γ , and through macrophage activation: TNF-α, IL1, IL6 (inflammation, shock) Cause of scarlet fever, toxic shock, flesh-eating fasciitis
32
scarlet fever: toxin
Streptococcus pyogenes
33
scarlet fever | Virulence factor:
a superantigen SPE | Streptococcal Pyrogenic Exotoxins
34
Other results of pyrogenic SPEs (2)
Pyoderma (impetigo) pyo = pus derma = skin skin infections of face, arms, legs Erysipelas erythros = red pella = skin bullae = blisters
35
Flesh-Eating: toxin
Strept.pyogenes | "streptococcal gangrene"
36
Progression to deep, systemic | infection leads to
multi-organ | failure and death.
37
---- is caused by streptococcus pyogenes
necrotizing fasciitis
38
Acute Pharyngitis = Strep throat (2) symptoms
``` glomerulonephritis (type 3 hypersensitivity) rheumatic fever (type 2 hypersensitivity) ```
39
acute rheumatic fever symptoms (2)
myocarditis | arthritis
40
Rheumatic Heart Disease by ---
Streptococci
41
``` Acute Rheumatic Fever: • non---- sequela with some strains • <---% of population is susceptible • fever is non-responsive to --- because disease is autoimmune •frequency of reoccurrence? ```
suppurative 10 penicillin high
42
``` Streptococcus agalactiae Group B (4) ```
β-hemolytic (<2% non-hemolytic), chain-like growth, aerobic, polysaccharide capsule
43
Group B, Normal occurrence in the --- Does not cause disease in healthy people
lower gastrointestinal tract
44
Group B, | where is it found? (4)
• pneumonia in neonates (neonates: <7 days of birth) • bacteremia and meningitis (neonates: >7 days of birth) • various symptoms in elderly suffering from chronic diseases (often complicated by penicillin allergy) • urinary infections, bacteremia (pregnant women)
45
--- against group B polysaccharide Ag develop quickly and protect.
Neutralizing antibodies | maternal Abs prevent infection of neonate
46
Strains different from S.pyogenes or S.agalactiae may cause opportunistic - -- e. g. in HIV-immune-compromised cases.
streptococcal toxic shock syndrome
47
Enterococcus faecalis | virulence
Ø high, multiple antibiotic resistances (plasmid and chromosomal)*
48
Enterococcus faecalis | Epidemiology
elderly long hospitalization (high nosocomial risk antibiotic resistance)
49
Streptococcus pneumoniae (3)
α-hemolytic, Gram+ diplococci
50
Streptococcus pneumoniae | causes per year in USA
500,000
51
Streptococcus pneumoniae Only --- strains (smooth colonies) are virulent
encapsulated
52
pneumococcal pneumonia (2) epidemiology prevention/tx
high carrier rates for s pneumoniae | capsular vaccine available
53
klebsiella pneumonia (4) cauative agent epidemiology (2) prevention/tx
an enterbacterium often resistant to antibiotics fatal nosocomial pneumonias no vaccine available
54
mycoplasmal pneumonia | prevention/tx
no vaccine available
55
Streptococcal pneumonia | treatment of choice
penicillin
56
S.pneumoniae virulence factors (3)
α-hemolysis capsule secretory IgA protease
57
meningitis
S.pneumoniae
58
Neisseria sp. (5)
• Gram− diplococci • Lipooligosaccharide (vs. LPS): lack O antigen extensions • common oral flora and other mucous membranes • facultative anaerobe • pathogens: N.gonorrhoeae and N.meningitidis Host: only humans
59
Ø --- variation and --- variation of pilin genes
phase | antigenic
60
Virulence Factors of N. gonorrhoeae | vaccination?
not possible
61
Virulence Factors of N. gonorrhoeae | capsule?
no
62
Pathogenesis of Gonorrhea | Antigenic variation of bacterial surface proteins (4)
ØPilE single chromosomal copy of pilin structural gene ØStrains contain 10-15 copies of PilE variants lacking promoter and 5-end of gene called PilS genes ØPilS genes recombine with PilE creating unlimited antigenic variants of PilE ØResult is that antigenic structure of pilus protein is constantly changing
63
Phase Variation:
on/off switch for surface protein expression
64
In Neisseriae:
Slipped Strand Mispairing resulting from presence of multiple identical repeated sequences at 5-end of gene. Replication errors due to strand misalignment creates reading frame errors. Often, premature stops, but also results in ON/OFF switch.
65
Multiple Opa (Colony Opacity) protein copies scattered across genome;
Slipped strand mispairing results in frequent variation in Opa protein expression or complete absence of Opa
66
Pathogenesis of Gonorrhea (2)
Ø Phase Variation: on/off switch Ø E. coli and other Gm- rods simple inversion of promoter
67
--- mediate bacterial attachment to non-ciliated epithelia | bacteria proliferate and shed into secretions; can also ente
Pili
68
Virulence Factors of N. gonorrhoeae | Ø secreted IgA protease:
``` Usefulness of cleaving IgA: Coating of bacteria with IgA Fab fragments (does not activate complement and also blocks binding by other IgG and IgM) ```
69
Serum-resistant virulent strains cause disseminated gonococcal infections: (2)
• Strains lack Opa proteins (colony opacity proteins = outer-membrane proteins) Neutrophils unable to engulf bacteria lacking Opa proteins. • Sialic acid on LOS (Lipidoligosaccharide of outer membrane) binds complement regulatory proteins, prevents complement-based phagocytosis.
70
Ø Shedding of lots of --- (LOS of these bacteria) Binds TLR-4 (especially on dendritic cells, macrophages, & B cells) secretion of pro-inflammatory --- (TNFalpha, IFN-gamma, IL-1,-12, & -18) & nitric oxide shock
endotoxin | cytokines
71
Gonorrheal Diseases | transmission
§ Sexual transmission - urogenital infections
72
Gonorrheal Diseases § Frequently (almost) --- o --- in men, urethral pus secretion (leukocytes with many gonococci) o --- in women, frequently some urination sensitivity but no other symptoms (infection tracing is important to prevent re-infection)
asymptomatic urethritis cervicitis
73
``` Gonorrheal Diseases Opthalmia Neonatorum (2) ```
o destructive eye infection, acquired during birth o Application of erythromycin ointment into both eyes of newborns is mandatory in many states and is considered standard neonatal care
74
Gonorrheal Diseases Pelvic Inflammatory Disease (PID) in women (3)
Initial infection of cervix, fallopian tubes and vaginal wall glands can lead to PID (15-30%): o gonococci enter abdominal cavity, cause liver disease o tissue scarring causes fallopian tube abnormalities which lead to ectopic pregnancies and sterility
75
Gonorrheal Diseases | Urethral and testicular tubule scarring, resulting from epididymitis, leads to (2)
sterility | and increased urethral infections by other microbes
76
Disseminated Gonococcal Infection (without apparent genital infection) causes (3)
skin | lesions, suppurative arthritis of a major joint, heart valve destruction.
77
Little or no --- (pilin variability!) is observed | after recovery from an infection with N.gonorrhoeae.
protective immunity
78
factors affecting intravascular survival (2)
capsule: protects against complement mediated bacteriolysis and phagocytosis acquisition of iron from transferrin
79
crossing of the blood brain barrier
multiplication in subarachnoid space
80
Neisseria meningitidis | Symptoms
start like a mild cold, progress to throbbing headache, fever, stiffness in neck and back, nausea and vomiting, deafness and coma. Shock and death (100% if untreated) may occur within 24 hours, but frequently is slower so that effective treatment can be given (<10% death in treated cases).
81
Neisseria meningitidis | Obstruction of release of increased fluid pressure (due to PMN attempts at eradication: pus and clotting) impairs
brain, causes paralysis of motor nerves and coma. Loss of blood supply to brain is one of the frequent symptoms just prior to death
82
Neisseria meningitidis LOS/endotoxin release from blood-circulating meningococci (which have a high tendency to auto-lyse and thus spread LOS widely) causes ---.
shock
83
Neisseria meningitidis Contrary to other meningitis-causing infections, small local skin hemorrhages are observed: Localized loss of vascular integrity: effect of
inflammatory cytokines release induced by endotoxin activation of macrophages.
84
Neisseria meningitidis | Purpura fulminans:
blood spots, bruising, and discoloration | of skin from coagulation in small blood vessels
85
Neisseria meningitidis | Can progress to disseminated intravascular coagulation:
blood clots throughout the circulatory system resulting in blockages and excessive bleeding elsewhere (clotting factors depleted)
86
Virulence Factors of N.meningitidis (4)
Ø Large capsule Ø IgA protease Ø Pili Ø Shedding of lots of Endotoxin shock
87
Ø Large capsule leads to
disseminated intravascular coagulation (DIC) Some virulent strains have capsules with sialic acid on LOS (like N.gonorrhea): reduces phagocytosis further
88
Effective vaccination against capsular polysaccharides (2)
MenACWY Vaccine – CDC recommended since 2005 Protection from 4 major disease-causing strains: A, C, W135 and Y (serotyping: 12 antigenic groups) MenB vaccine – approved in 2014 & also recommended B capsule poly-sialic acid; Andy Marso’s case involved serogroup B bacteria. European MenB vaccine was used in outbreaks at Princeton and UC Santa Barbara in 2013-2014
89
q Mandatory vaccination for students living in dorms | in many states, military recruits, and jail inmates
N.meningitidis
90
N.species: N.gonorrhoeae "gonococci" Virulence factors Clinical features Epidemiology
pili, Ag-variation adhesins, OPA IgA protease endotoxin/LOS gonorrhea (Ch.69) pelvic inflammatory disease arthritis (Ch.65, 70) sexual transmission asymptomatic carrier
91
``` N.species: N.meningitidis "meningococci" Virulence factors Clinical features Prevention Epidemiology ```
``` polysaccharide capsule endotoxin/LOS Pili IgA protease ``` meningitis (Ch.61) meningococcemia (bacteremia) Prevention: MenACWY & MenB vaccines asymptomatic carrier aerosol transmission children/young adults
92
Gram− bacteria of the human colon/oral cavity
Bacteroides
93
Bacteroidales (3)
Strict anaerobes Commensals Opportunistic pathogens
94
Bacteroides fragilis (2)
- most frequently isolated from clinical specimens of abscesses caused by intestinal bacteria - most oxygen-resistant Bacteroides
95
Bacteroidales | Virulence Factors: (3)
Ø Superoxide dismutase - detoxifies oxygen radicals Ø Catalase - breaks down hydrogen peroxide Ø Polysaccharide capsule
96
Ø Superoxide dismutase - detoxifies oxygen radicals Ø Catalase - breaks down hydrogen peroxide allows for
survival in well oxygenated peritoneal cavity | Also helps bacteria resisting killing by phagocytosis
97
Bacteroidales Disease caused when examples (2)
bacteria are introduced into deep tissues - peritonitis - rupture of infected appendix/diverticulum - pulmonary abscess - aspiration of oropharyngeal bacteria
98
Bacteroides fragilis is one component in these diseases --- --- --- - start with acute inflammation progress to formation of localized abscesses --- as disease progresses 100’s of different species in inoculum few species in abscess due to response of the host and features of individual bacterial species
polymicrobial diseases biphasic bacterial composition changes
99
Bacteroidales | Course of disease
perforation of intestine/spillage of intestinal fluid neutrophils mobilized surviving bacteria resistant to phagocytosis B. fragilis has a capsule oxygen-sensitive bacteria are killed peritoneal cavity well-oxygenated facultative anaerobes grow first (E. coli) some strict anaerobes survive site becomes anaerobic surviving strict anaerobes become predominant
100
Bacteroidales | treat with
Surgery and antibiotic combinations (target aerobes and anaerobes)